Fleur Goldthorpe

Position: Current PhD Student
School and/or Centres: School of History

Email: fleur.goldthorpe@anu.edu.au

Location: Level 5, Room 5.40, Desk F, 146 Ellery Cres


Bachelor of Laws (LLB) and Bachelor of Science (BSc), (2005) Otago University, Dunedin, New Zealand Graduate Certificate in Business Studies (Finance) (2011) Solicitor - Supreme Court of Queensland Solicitor - High Court of Australia Admitted as a Solicitor and Barrister - High Court of New Zealand

Thesis title: British Women of the Portocracy: Port Wine Dinastias, Family and Transcultural Lives, 1678-1855

Fleur is a PhD candidate in the School of History, College of Arts and Social Sciences undertaking the research project ‘British Women of the Portocracy: Port Wine Dinastias, Family and Transcultural Lives, 1678-1855’.

Port is a fortified wine produced in the Douro Valley in northern Portugal. First shipped to England in 1678, port swiftly became the ‘Englishman’s wine.’ British merchants migrated to Porto, living transnationally to establish and run businesses as producers and shippers. This British community, colloquially known as the ‘Portocracy,’ endures today three centuries later. The current port wine history documents the British men, but what of their wives, daughters and sisters?

On 24 January 2018, Fleur was awarded the National Council of Women (NSW) Australian History Award in recognition of a piece of research additional to her PhD Research looking into women exhibitors of Australian colonial wine at international and intercolonial exhibitions of the nineteenth century. As a wine historian she is focusing on highlighting women's contributions to the wine industry hoping their stories inspire more women today to enter the trade.

Prior to commencing her post-graduate research, Fleur worked for nearly a decade in the field of technology commercialisation, translating research outputs into new products and services. Most recently she managed the Australian multi-site Phase 1 trial for safety and tolerability of the novel immunomodulatory agent Pixatimod (PG545) by IV administration in patients with advanced cancer. Pixatimod is now in Phase 1b clinical trials where it is being tested in combination with Bristol-Myers Squibb's checkpoint inhibitor Nivolumab (Opdivo) in patients with pancreatic ductal adenocarcinoma, microsatellite stable metastatic colorectal cancer or advanced cancer. The drug is also now in pre-clinical development as an anti-viral drug against COVID-19 following successful in vitro live virus infectivity studies which demonstrated that it binds directly to the SARS-CoV-2 spike protein S1 receptor binding domain, altering its conformation and leading to effective inhibition of viral infectivity.

She previously held senior executive positions in oncology drug development company Progen Pharmaceuticals Ltd (Brisbane, Australia) biotechnology company Immune Solutions Ltd (Dunedin, New Zealand) and the University of Otago's commercialisation office Otago Innovation Ltd (Dunedin, New Zealand).

Fleur holds a Bachelor of Science and a Bachelor of Laws from the University of Otago in New Zealand. She has over ten years' post admission experience as a solicitor in Australia and New Zealand. Complimenting her wine history research, Fleur holds the wine industry qualification of the Wine and Spirits Education (WSET) Level 3 Advanced Certificate and is currently undertaking the WSET Diploma.

British History
Anglo-Portuguese Studies
Australian Colonial History
European History
Family Business Studies
International Wine Studies
Early Modern History
Portuguese History
Migration and Transculturalism
Women and Wine

Economic history


Fleur Goldthorpe (2021) Women in International and Universal Exhibitions, 1876–1937, Women's History Review, 30:1, 174-176

DOI: 10.1080/09612025.2019.1703505


Dredge, K., Brennan, T., Hammond, E., Brown, M. P., Lickliter, J. D., Lin, L., Bampton, D., Handley, P., Lankesheer, F., Morrish, G., Yang, Y., and Millward, M. (2018) An open-label, multi-center phase I study of the safety and tolerability of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumors. British Journal of Cancer 118, 1035-1041.



Hammond, E., Haynes, N. M., Cullinane, C., Brennan, T.V., Bampton, D., Handley, P., Tomislav, K., Lankesheer, F., Lin, L., Yang, Y., Dredge, K. (2018) Immunomodulatory activities of pixatimod: Emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors. Journal for ImmunoTherapy of Cancer, 6:54




‘The woman behind Australia’s most successful wine label’, The Drinks Business, Sept 2017


2018 - National Council of Women (NSW) Australian History Award

Australian Government Research Training Program Domestic Scholarship (2019)

Australian Historical Association
Australian Women’s History Network
American History Association
Association of Business Historians
Berkshire Conference of Women Historians
British Association for Victorian Studies
British Historical Society of Portugal
Women’s Studies Group 1558-1837

ECHI1006 – The Australian Economy: Past and Present (2020)

EURO1004 – Europe in the Modern Era (2019 & 2021)


Updated:  26 May 2021/Responsible Officer:  Head of School/Page Contact:  CASS Marketing & Communications